tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DSKYF Stock Latest News

Bayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
Company AnnouncementsBayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
13d ago
Daiichi Sankyo Reports January Progress on Ongoing Share Buyback Program
PremiumCompany Announcements
Daiichi Sankyo Reports January Progress on Ongoing Share Buyback Program
15d ago
Daiichi Sankyo Publishes Q3 FY2025 Consolidated Financial Reference Data
PremiumCompany Announcements
Daiichi Sankyo Publishes Q3 FY2025 Consolidated Financial Reference Data
18d ago
Daiichi Sankyo Company (DSKYF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Daiichi Sankyo Company (DSKYF) Q3 Earnings Cheat Sheet
20d ago
TROPION-SWISH: New Phase IV Study Targets Side-Effect Risk in AstraZeneca and Daiichi Sankyo’s Dato-DXd
PremiumCompany Announcements
TROPION-SWISH: New Phase IV Study Targets Side-Effect Risk in AstraZeneca and Daiichi Sankyo’s Dato-DXd
26d ago
AZN
Daiichi Sankyo and Merck Advance Novel ADC Combo in Tough-to-Treat Lung Cancer
PremiumCompany AnnouncementsDaiichi Sankyo and Merck Advance Novel ADC Combo in Tough-to-Treat Lung Cancer
2M ago
DSKYF
Daiichi Sankyo’s Next Lung Cancer Bet: What the New Merck Partnership Study Means for Investors
Premium
Company Announcements
Daiichi Sankyo’s Next Lung Cancer Bet: What the New Merck Partnership Study Means for Investors
2M ago
DSKYF
Daiichi Sankyo’s ADC Push in Gastroesophageal Cancer: What Substudy 06D Means for Investors
Premium
Company Announcements
Daiichi Sankyo’s ADC Push in Gastroesophageal Cancer: What Substudy 06D Means for Investors
2M ago
DSKYF
TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
PremiumCompany Announcements
TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
2M ago
AZN
Daiichi Sankyo’s CLEAR Taiwan Study: A New Chapter in Lipid-Lowering Therapy
PremiumCompany Announcements
Daiichi Sankyo’s CLEAR Taiwan Study: A New Chapter in Lipid-Lowering Therapy
2M ago
DSKYF
3 Best Japanese Stocks to Invest In, According to AI Analyst
PremiumMarket News
3 Best Japanese Stocks to Invest In, According to AI Analyst
2M ago
GS
AZN
Daiichi Sankyo Wins Patent Dispute Appeal Against Seagen
PremiumCompany Announcements
Daiichi Sankyo Wins Patent Dispute Appeal Against Seagen
3M ago
DSKYF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsDSKYF Upcoming Earnings Report: What to Expect?
4M ago
Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment
Premium
Company Announcements
Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment
4M ago
DSKYF
Daiichi Sankyo’s Promising Pediatric Cancer Study: A Potential Game-Changer
Premium
Company Announcements
Daiichi Sankyo’s Promising Pediatric Cancer Study: A Potential Game-Changer
4M ago
DSKYF
Daiichi Sankyo’s Promising Gastrointestinal Cancer Study: A Market Game-Changer?
PremiumCompany Announcements
Daiichi Sankyo’s Promising Gastrointestinal Cancer Study: A Market Game-Changer?
4M ago
DSKYF
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Gastrointestinal Cancer Treatment
PremiumCompany Announcements
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Gastrointestinal Cancer Treatment
4M ago
DSKYF
Daiichi Sankyo’s Promising Breast Cancer Study: A Financial Perspective
PremiumCompany Announcements
Daiichi Sankyo’s Promising Breast Cancer Study: A Financial Perspective
4M ago
DSKYF
Daiichi Sankyo’s Promising Phase 2 Breast Cancer Study: A Potential Game-Changer
PremiumCompany Announcements
Daiichi Sankyo’s Promising Phase 2 Breast Cancer Study: A Potential Game-Changer
4M ago
DSKYF
Daiichi Sankyo’s Promising Study on Innovative Lung Cancer Treatments
PremiumCompany AnnouncementsDaiichi Sankyo’s Promising Study on Innovative Lung Cancer Treatments
4M ago
DSKYF
Daiichi Sankyo’s Promising Phase 3 Trial: A Potential Game-Changer in Gastric Cancer Treatment
Premium
Company Announcements
Daiichi Sankyo’s Promising Phase 3 Trial: A Potential Game-Changer in Gastric Cancer Treatment
4M ago
DSKYF
Daiichi Sankyo’s Quizartinib Trial: A New Hope for AML Treatment?
Premium
Company Announcements
Daiichi Sankyo’s Quizartinib Trial: A New Hope for AML Treatment?
4M ago
DSKYF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >